In contrast to IL‐22−/−/PyMT mice, tumors in control mice progressed to the malignant transition stage and cancer cells appeared pleomorphic with moderate variation in nuclear morphology, size, and shape (Fig. 2A). The gene discussed is IL22; the disease is cancer.